PortfoliosLab logoPortfoliosLab logo

Janus Henderson Global Life Sciences Fund (JNGLX) Alternatives

Janus Henderson Global Life Sciences Fund (JNGLX) belongs to the Health & Biotech Equities category. Below you'll find alternative mutual funds from the same category, ranked by key criteria, plus funds that investors commonly compare with JNGLX. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.

Cheapest Alternatives to JNGLX

JNGLX charges 0.80% annually. Among mutual funds in the Health & Biotech Equities category, these options have the lowest expense ratios among JNGLX alternatives.


Best Risk-Adjusted Alternatives to JNGLX

Among mutual funds in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.


Top Performing JNGLX Alternatives (YTD)

JNGLX alternatives from the Health & Biotech Equities category, sorted by year-to-date return.


Lowest Volatility Alternatives to JNGLX

JNGLX alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.


Lowest Drawdown Alternatives to JNGLX

JNGLX alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.


Other Mutual Funds from Janus Henderson

Most popular Janus Henderson mutual funds on PortfoliosLab, across asset classes.


Often Compared With JNGLX

What investors most often compare with JNGLX, based on PortfoliosLab usage data.


Compare JNGLX with Any Fund or Stock

Compare JNGLX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.